Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features

Carcinogenesis

Volumn 35, Issue 10, 2014, Pages 2224-2231

  Arima, Chinatsu ^a   Kajino, Taisuke ^a   Tamada, Yoshinori ^b   Imoto, Seiya ^b   Shimada, Yukako ^a   Nakatochi, Masahiro ^c   Suzuki, Motoshi ^a   Isomura, Hisanori ^a   Yatabe, Yasushi ^d   Yamaguchi, Tomoya ^a   Yanagisawa, Kiyoshi ^a   Miyano, Satoru ^b   Takahashi, Takashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 195; MICRORNA 30D; UNCLASSIFIED DRUG; MIRN195 MICRORNA, HUMAN; MIRN30 MICRORNA, HUMAN;

ARTICLE; EPIGENETICS; GENE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER CELL LINE; LUNG DEVELOPMENT; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; RRM2 GENE; ADENOCARCINOMA; BAYES THEOREM; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; LUNG; LUNG TUMOR; PATHOLOGY;

ADENOCARCINOMA; BAYES THEOREM; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; LUNG; LUNG NEOPLASMS; MICRORNAS;

EID: 84926452140     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu127     Document Type: Article

References (29)

1. Travis, W.D. et al. (2011) International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol., 6, 244-285.
2. Yamaguchi, T. et al. (2013) NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression. Cancer Cell, 23, 718-723.
3. Yatabe, Y. et al. (2002) TTF-1 expression in pulmonary adenocarcinomas. Am. J. Surg. Pathol., 26, 767-773.
4. Tanaka, H. et al. (2007) Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res., 67, 6007-6011.
5. Takeuchi, T. et al. (2006) Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J. Clin. Oncol., 24, 1679-1688.
6. Yatabe, Y. et al. (2005) EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am. J. Surg. Pathol., 29, 633-639.
7. Weir, B.A. et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature, 450, 893-898.
8. Cancer Genome Atlas Research Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature, 489, 519-525.
9. Osada, H. et al. (2007) MicroRNAs in biological processes and carcinogenesis. Carcinogenesis, 28, 2-12.
10. Takamizawa, J. et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 64, 3753-3756.
11. Hayashita, Y. et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res., 65, 9628-9632.
12. Matsubara, H. et al. (2007) Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene, 26, 6099-6105.
13. Ebi, H. et al. (2009) Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene, 28, 3371-3379.
14. Taguchi, A. et al. (2008) Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res., 68, 5540-5545.
15. Ventura, A. et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 132, 875-886.
16. Lu, Y. et al. (2007) Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol., 310, 442-453.
17. Hanahan, D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
18. Lefebvre, C. et al. (2012) Reverse-engineering human regulatory networks. Wiley Interdiscip. Rev. Syst. Biol. Med., 4, 311-325.
19. Takahashi, T. et al. (1986) Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Cancer Res., 46, 4770-4775.
20. Ebi, H. et al. (2009) Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. Cancer Res., 69, 4027-4035.
21. Tomida, S. et al. (2009) Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J. Clin. Oncol., 27, 2793-2799.
22. Eisen, M.B. et al. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. U. S. A., 95, 14863-14868.
23. Dong, J. et al. (2010) MicroRNA networks in mouse lung organogenesis. PLoS One, 5, e10854.
24. Tamada, Y. et al. (2011) Sign: large-scale gene network estimation environment for high performance computing. Genome Inform., 25, 40-52.
25. Yamaguchi, T. et al. (2012) NKX2-1/TITF1/TTF-1-induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell, 21, 348-361.
26. Nishikawa, E. et al. (2011) miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res., 71, 6165-6173.
27. Morrisey, E.E. et al. (2010) Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev. Cell, 18, 8-23.
28. Nordlund, P. et al. (2006) Ribonucleotide reductases. Annu. Rev. Biochem., 75, 681-706.
29. Tanaka, H. et al. (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature, 404, 42-49.